Search Results - Tomás García-Caballero

The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile by Alana Aragón-Herrera, Alana Aragón-Herrera, Manuel Otero-Santiago, Laura Anido-Varela, Sandra Moraña-Fernández, Manuel Campos-Toimil, Tomás García-Caballero, Luis Barral, Estefanía Tarazón, Estefanía Tarazón, Esther Roselló-Lletí, Esther Roselló-Lletí, Manuel Portolés, Manuel Portolés, Oreste Gualillo, Isabel Moscoso, Ricardo Lage, José Ramón González-Juanatey, José Ramón González-Juanatey, Sandra Feijóo-Bandín, Sandra Feijóo-Bandín, Francisca Lago, Francisca Lago

Connect to this object online.